```html

Uncomplicated Migraine – A Complete Medical Guide

Overview

A migraine is a recurrent, moderate‑to‑severe headache disorder that is often described as a throbbing pain on one side of the head. Uncomplicated migraine (also called “migraine without aura”) is the most common form; it does not involve the visual or sensory disturbances (aura) that characterize “migraine with aura.”

Migraine affects approximately 12 % of the global population (about 1 in 8 people) and is the third most prevalent disease worldwide, according to the World Health Organization (WHO). In the United States, the CDC estimates that ~39 million adults experience migraine each year, with women being three times more likely than men to be affected (18 % vs. 6 %). The condition often begins in adolescence or early adulthood, with the highest incidence between ages 25–45, but migraine can occur at any age.

Symptoms

Symptoms of uncomplicated migraine typically develop in a predictable pattern.

Headache Characteristics

• Pulsating or throbbing pain – most often unilateral (one side), but may become bilateral.
• Moderate to severe intensity – often described as 6‑8 on a 10‑point pain scale.
• Aggravation by routine physical activity (e.g., climbing stairs).

Associated Symptoms

• Nausea and/or vomiting.
• Photophobia – increased sensitivity to light.
• Phonophobia – increased sensitivity to sound.
• Osmophobia – heightened sensitivity to odors (e.g., perfume, cigarette smoke).

Typical Course

• Attack duration: 4–72 hours if untreated.
• Prodrome (pre‑headache) phase (optional): mood changes, food cravings, neck stiffness, yawning 24‑48 h before the pain.
• Post‑drome (after‑effects) phase (optional): feeling “drained,” difficulty concentrating, mild headache for up to 24 h.

Causes and Risk Factors

The exact cause of migraine is not fully understood, but it is believed to involve a combination of genetic, vascular, and neurological factors.

Underlying Mechanisms

• Trigeminovascular system activation – releases vasoactive peptides (e.g., CGRP) causing inflammation of meningeal blood vessels.
• Cortical spreading depression – a wave of neuronal depolarisation that may trigger the pain pathway.
• Serotonin (5‑HT) dysregulation – influences blood‑vessel tone and pain perception.

Risk Factors

• Family history – first‑degree relatives increase risk up to 3‑fold.
• Female sex – estrogen fluctuations (menstruation, pregnancy, menopause) are powerful triggers.
• Age – most common 20‑45 years.
• Hormonal medications – oral contraceptives, hormone replacement therapy.
• Stress, anxiety, or depression.
• Sleep disturbances (insomnia, oversleeping).
• Dietary triggers – aged cheese, processed meats, caffeine, alcohol (especially red wine).
• Environmental factors – bright lights, loud noises, strong odors, changes in weather.
• Medication overuse – frequent use of analgesics (>10 days/month) can lead to rebound headaches.

Diagnosis

Diagnosis is primarily clinical, based on the patient’s history and symptom pattern. No single laboratory test confirms migraine, but certain investigations are performed to rule out secondary causes.

Clinical Criteria (ICHD‑3)

• At least 5 attacks fulfilling the following:
• Headache lasting 4‑72 hours (untreated or unsuccessfully treated).
• At least two of the following pain qualities: unilateral location, pulsating quality, moderate–severe intensity, aggravation by routine physical activity.
• During headache, at least one of the following: nausea and/or vomiting, photophobia, phonophobia.
• Not attributable to another disorder.

When Additional Testing is Considered

• New onset after age 50.
• Atypical features (e.g., progressive worsening, neurological deficits).
• Headache triggered by coughing, Valsalva, or positional changes.

Imaging (MRI or CT) is ordered in those scenarios to exclude intracranial pathology. Routine blood work is rarely required unless systemic illness is suspected.

Treatment Options

Therapy is divided into acute (abortive) treatment to stop an ongoing attack and preventive treatment to reduce attack frequency.

Acute Medications

• Non‑prescription pain relievers – acetaminophen, ibuprofen, naproxen. Best if taken early (<2 h).
• Triptans – sumatriptan, rizatriptan, zolmitriptan; serotonin 5‑HT₁B/₁D agonists that constrict cranial blood vessels and inhibit CGRP release.
• Ergots – dihydroergotamine (IV, nasal spray) for patients who cannot use triptans.
• Anti‑nausea agents – metoclopramide or prochlorperazine for vomiting.
• Combination analgesics – triptan + NSAID (e.g., sumatriptan/naproxen) shown to improve pain‑free rates (Mayo Clinic, 2023).

Preventive Medications

Consider when attacks are ≥4 per month, severely disabling, or when acute meds are overused.

• Beta‑blockers – propranolol, metoprolol.
• Anticonvulsants – topiramate, valproate.
• Tricyclic antidepressants – amitriptyline.
• CGRP‑targeted therapies – erenumab, fremanezumab, galcanezumab (monthly injections); effective in >50 % of patients (NEJM, 2022).
• Botulinum toxin A – onabotulinumtoxinA, FDA‑approved for chronic migraine; may be used in refractory episodic migraine.

Non‑Pharmacologic Measures (Both Acute & Preventive)

• Apply a cold compress or ice pack to the forehead or occiput.
• Rest in a dark, quiet room; use eye masks or earplugs.
• Practice **relaxation techniques** – diaphragmatic breathing, progressive muscle relaxation, guided imagery.
• **Hydration** – aim for 2–3 L of water daily.
• **Caffeine timing** – a small dose (≈100 mg) early in an attack can boost triptan efficacy, but avoid excess.
• **Physical therapy** for neck and shoulder tension.

Procedural Options (Rarely Needed for Uncomplicated Migraine)

• **Occipital nerve block** – short‑term relief for refractory attacks.
• **Transcranial magnetic stimulation (TMS)** – FDA‑cleared single‑pulse device for acute treatment.
• **Sphenopalatine ganglion (SPG) stimulation** – emerging therapy, studied in clinical trials.

Living with Uncomplicated Migraine

Successful self‑management hinges on recognizing triggers, maintaining a headache diary, and establishing routines that support overall wellbeing.

Daily Management Tips

• Keep a migraine diary (date, time, foods, sleep, stress level, medication taken, response).
• Maintain **consistent sleep** – 7–9 hours, same bedtime/wake‑time daily.
• Follow a **regular meal schedule**; avoid skipping meals.
• Limit **caffeine** to ≤200 mg/day and avoid abrupt withdrawal.
• Stay **physically active** – 150 min/week of moderate aerobic activity; begin slowly if acute pain limits exercise.
• Practice **stress‑reduction** daily (mindfulness, yoga, tai chi).
• Identify **environmental triggers** (bright computer screens, strong perfumes) and modify exposure.
• Carry a **personal rescue medication** (e.g., triptan) and know when to take it (early in the attack).

Workplace Strategies

• Discuss accommodations with HR: flexible scheduling, ability to work in a dimly lit space.
• Keep a **low‑light, quiet area** or a small “recovery kit” (eye mask, earplugs, medication) at work.
• Educate trusted colleagues about migraine so they can offer support during an attack.

Prevention

Preventive measures aim to lower attack frequency and reduce reliance on acute medications.

Lifestyle Prevention

• Adopt a **Mediterranean‑style diet** rich in fruits, vegetables, whole grains, fish, and olive oil – associated with 20‑30 % lower migraine risk (Harvard Health, 2021).
• Maintain a **healthy body weight**; obesity increases migraine frequency by ~30 %.
• Implement **regular aerobic exercise** (e.g., brisk walking, swimming) at least three times weekly.
• Use **biofeedback** or **cognitive‑behavioral therapy (CBT)** – evidence shows 50‑60 % reduction in attack days (Cleveland Clinic, 2022).

Medical Prevention

• Start prophylactic medication if ≥4 disabling attacks per month or if acute medication use exceeds 10 days/month.
• Review all over‑the‑counter pain relievers; limit to ≤2 days/week to avoid medication‑overuse headache.
• Consider **menstrual‑related migraine protocols** (e.g., short‑course triptan or NSAID during perimenstrual window).

Complications

When left untreated or poorly managed, uncomplicated migraine can lead to:

• Medication‑overuse headache – worsening headache frequency due to frequent analgesic use.
• Progression to **chronic migraine** (≥15 headache days/month for >3 months); occurs in ~2–3 % of migraineurs.
• Reduced quality of life: impaired work productivity, school attendance, and social participation.
• Psychiatric comorbidities – higher rates of depression and anxiety (up to 40 % in some cohorts).
• In rare cases, increased risk of cardiovascular events with certain triptans in patients with underlying heart disease.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH (National Institute of Neurological Disorders and Stroke), WHO, Cleveland Clinic, New England Journal of Medicine, Harvard Health Publishing, ICHD‑3 (International Classification of Headache Disorders, 3rd edition).

```